Menu Search
Equities

MED SA

MED:ATH

MED SA

Actions
  • Price (EUR)0.945
  • Today's Change0.035 / 3.85%
  • Shares traded75.50k
  • 1 Year change-1.56%
  • Beta--
Data delayed at least 20 minutes, as of Nov 15 2024 14:44 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year MED SA's revenues fell -7.54% from 4.54m to 4.20m. a gain of 83.86k to a loss of 271.05k.
Gross margin79.86%
Net profit margin-21.53%
Operating margin-22.62%
Return on assets-8.11%
Return on equity-45.39%
Return on investment-13.92%
More ▼

Cash flow in EURView more

In 2023, MED SA increased its cash reserves by 239.81%, or 885.32k. Cash Flow from Investing totalled 520.59k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 12.56k in cash from operations while cash generated from financing totalled 352.17k.
Cash flow per share0.008
Price/Cash flow per share113.60
Book value per share0.1348
Tangible book value per share0.1259
More ▼

Balance sheet in EURView more

MED SA has a Debt to Total Capital ratio of 57.31%, a lower figure than the previous year's 126.06%.
Current ratio2.12
Quick ratio0.8119
Total debt/total equity3.01
Total debt/total capital0.5731
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.